Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
Garred
P
P
Eugen-Olsen
J
J
Iversen
A K
AK
Benfield
T L
TL
Svejgaard
A
A
Hofmann
B
B
D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics* / Q000276:immunology / Q000401:mortality; D000483:Alleles; D018791:CD4 Lymphocyte Count; D005500:Follow-Up Studies; D017353:Gene Deletion; D006679:HIV Seropositivity / Q000235:genetics* / Q000276:immunology / Q000401:mortality; D015497:HIV-1 / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008297:Male; D019713:Receptors, CCR5; D018121:Receptors, Cytokine / Q000235:genetics*; D015728:Receptors, HIV / Q000235:genetics*; D015996:Survival Rate
D019713:Receptors, CCR5; D018121:Receptors, Cytokine; D015728:Receptors, HIV